2. Network meta‐analysis, random‐effects model.
Treatment | RR | 95% CI | 95% PI |
bupi | 0.19 | 0.12 to 0.29a | 0.12 to 0.30 |
chloro | 0.18 | 0.02 to 1.53 | 0.02 to 1.75 |
levo | 0.17 | 0.04 to 0.70a | 0.04 to 0.77 |
mepi | 1.54 | 0.76 to 3.12 | 0.73 to 3.27 |
prilo | 0.23 | 0.10 to 0.55a | 0.09 to 0.58 |
pro | 0.17 | 0.05 to 0.56a | 0.05 to 0.60 |
ropi | 0.10 | 0.01 to 0.78a | 0.01 to 0.89 |
bupi: bupivacaine; chloro: 2‐chloroprocaine; CI: confidence Interval; levo: levobupivacaine; lido: lidocaine; mepi: mepivacaine; PI: prediction interval; prilo: prilocaine; pro: procaine, ropi: ropivacaine. aNull hypothesis of no difference rejected.